In this article, Dr. Alberto Esquenazi and colleagues argue that spastic paresis is a neurological movement disorder, as it involves both excess movement and reduced voluntary and involuntary movements. The authors propose therapeutic strategies for its management. pubmed.ncbi.nlm.nih.gov/39548808/
Spastic Paresis: A Treatable Movement Disorder.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2024 – Jan 2025Where it's discussed
-
Facebook3 posts
-
X / Twitter1 posts
-
Bluesky1 posts
-
YouTube1 videos
AI synopsis
What people are saying
Participants generally agree with the viewpoint that spastic paresis involves both hypo- and hyperkinetic components, highlighting its complex motor features, with some references to the potential for therapy strategies. The tone suggests curiosity and professional interest, especially about the classification debate and therapeutic approaches, contributing to a moderately impactful discussion overall.
Most discussions align with the authors' view that spastic paresis should be classified as a distinct movement disorder, emphasizing its complex nature.
The discourse shows high interest, with participants intrigued by the classification debates and therapeutic strategies proposed.
Comments engage with the article by discussing its implications and suggesting further research, indicating a moderate depth of involvement.
The discussions reflect recognition of some impact, particularly in how the classification might influence future treatments and understanding.
Abstract in brief
- Spastic paresis is a type of movement disorder characterized by weakness and increased muscle tone, which causes stiffness and difficulty in movement.
- It is considered a treatable condition, meaning with proper diagnosis and therapy, symptoms can often be improved or managed.
- The condition typically results from damage to the nervous system, such as from a stroke, brain injury, or neurological disease, but early intervention can lead to better outcomes.
Top posts
Most liked on X and BlueskyShould spastic paresis be considered a distinct movement disorder, one with a mix of hypo- and hyperkinetic components? Members of MDS’s Spasticity Study Group make the case in this newly published viewpoint. @MDJ_Journal https://t.co/3lPG5fHFdw
All mentions
Advances in Spasticity Management Beyond Botulinum Toxin
This episode summarizes recent scientific articles on neurophysiological concepts, evaluation, and treatment of spasticity, highlighting emerging therapies like phenol neurolysis, cryoneurolysis, and shock wave therapy…
Should spastic paresis be considered a distinct movement disorder, one with a mix of hypo- and hyperkinetic components? Members of MDS’s Spasticity Study Group make the case in this newly published viewpoint. @MDJ_Journal https://t.co/3lPG5fHFdw
In this article, Dr. Alberto Esquenazi and colleagues argue that spastic paresis is a neurological movement disorder, as it involves both excess movement and reduced voluntary and involuntary movements. The authors propose therapeutic strategies for its management. pubmed.ncbi.nlm.nih.gov/39548808/